These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 29754722)
1. Lung cancer in pregnancy - Report of a case treated with crizotinib. Padrão E; Melo C; Fernandes G; Magalhães A Pulmonology; 2018; 24(3):205-207. PubMed ID: 29754722 [No Abstract] [Full Text] [Related]
2. Antineoplastic treatment with crizotinib during pregnancy: a case report. Jensen KH; Persson G; Storgaard L; Nielsen BB; Pedersen BW; Maroun LL; Huitema A; Pøhl M Acta Oncol; 2019 Jan; 58(1):121-122. PubMed ID: 30101631 [No Abstract] [Full Text] [Related]
3. Long-term Survival Associated with Crizotinib in a Lung Cancer Patient with a Pulmonary Artery Embolism. Shen Q; Dong XQ; Zhou JY Chin Med J (Engl); 2018 Jan; 131(1):111-112. PubMed ID: 29271393 [No Abstract] [Full Text] [Related]
4. Mutation of MET Y1230 as an Acquired Mechanism of Crizotinib Resistance in NSCLC with MET Exon 14 Skipping. Schrock AB; Lai A; Ali SM; Miller VA; Raez LE J Thorac Oncol; 2017 Jul; 12(7):e89-e90. PubMed ID: 28629543 [No Abstract] [Full Text] [Related]
5. Precision medicine at its best: Prolonged survival in a child presenting a secondary mesothelioma treated with crizotinib. Petit A; Lantuejoul S; Mc Leer A; Mondet J; Piolat C; Durand C; Moro-Sibilot D; Geoerger B; Vassal G; Sartelet H; Plantaz D Pediatr Blood Cancer; 2021 Feb; 68(2):e28666. PubMed ID: 32896951 [No Abstract] [Full Text] [Related]
6. A Complex Renal Cyst in a Patient on Crizotinib: Case Report. Liaw CW; Palese M; Fabrizio LD Urology; 2019 Sep; 131():21-23. PubMed ID: 31078629 [No Abstract] [Full Text] [Related]
7. Next-Generation Sequencer Analysis of Pulmonary Pleomorphic Carcinoma With a CD74-ROS1 Fusion Successfully Treated With Crizotinib. Mizuno T; Fujiwara Y; Yoshida K; Kohno T; Ohe Y J Thorac Oncol; 2019 May; 14(5):e106-e108. PubMed ID: 31027745 [No Abstract] [Full Text] [Related]
8. Lung cancer during pregnancy: an emerging issue. Pavlidis N Lung Cancer; 2008 Mar; 59(3):279-81. PubMed ID: 18022730 [No Abstract] [Full Text] [Related]
9. A Low Crizotinib Concentration in the Cerebrospinal Fluid Causes Ineffective Treatment of Anaplastic Lymphoma Kinase-positive Non-small Cell Lung Cancer with Carcinomatous Meningitis. Okimoto T; Tsubata Y; Hotta T; Hamaguchi M; Nakao M; Hamaguchi SI; Hamada A; Isobe T Intern Med; 2019 Mar; 58(5):703-705. PubMed ID: 30333394 [TBL] [Abstract][Full Text] [Related]
10. Crizotinib-induced lichenoid drug eruption in a patient with lung cancer. Ho YH; Chen CL Cutis; 2018 Dec; 102(6):403-406. PubMed ID: 30657798 [TBL] [Abstract][Full Text] [Related]
11. Crizotinib in advanced non-small-cell lung cancer with concomitant ALK rearrangement and c-Met overexpression. Chen RL; Zhao J; Zhang XC; Lou NN; Chen HJ; Yang X; Su J; Xie Z; Zhou Q; Tu HY; Zhong WZ; Yan HH; Guo WB; Wu YL; Yang JJ BMC Cancer; 2018 Nov; 18(1):1171. PubMed ID: 30477470 [TBL] [Abstract][Full Text] [Related]
12. Renal Injury during Long-Term Crizotinib Therapy. Yasuma T; Kobayashi T; D'Alessandro-Gabazza CN; Fujimoto H; Ito K; Nishii Y; Nishihama K; Baffour Tonto P; Takeshita A; Toda M; Gabazza EC; Taguchi O; Yonemura S; Hataji O Int J Mol Sci; 2018 Sep; 19(10):. PubMed ID: 30257437 [TBL] [Abstract][Full Text] [Related]
13. Brigatinib versus crizotinib for ALK-positive NSCLC. Stirrups R Lancet Oncol; 2018 Nov; 19(11):e585. PubMed ID: 30293790 [No Abstract] [Full Text] [Related]
14. Benefit of crizotinib in a lung cancer patient with discordant ALK testing results. Grocholski S; Banerji S; Qing G; Dawe DE Cancer Treat Res Commun; 2018; 15():13-16. PubMed ID: 30207282 [TBL] [Abstract][Full Text] [Related]
15. Successful Treatment of Non-Small Cell Lung Cancer With Erlotinib Throughout Pregnancy. Ji Y; Schwartz J; Hartford A; Ramsey J; Phillips J; Verschraegen C JAMA Oncol; 2015 Sep; 1(6):838-40. PubMed ID: 26181671 [No Abstract] [Full Text] [Related]
16. Neoadjuvant chemotherapy for advanced stage cervical cancer in a pregnant patient: report of one case with rapid tumor progression. Benhaim Y; Pautier P; Bensaid C; Lhommé C; Haie-Meder C; Morice P Eur J Obstet Gynecol Reprod Biol; 2008 Feb; 136(2):267-8. PubMed ID: 17157432 [No Abstract] [Full Text] [Related]
17. Effectiveness of crizotinib in a patient with ALK IHC-positive/FISH-negative metastatic lung adenocarcinoma. Rosoux A; Pauwels P; Duplaquet F; D'Haene N; Weynand B; Delos M; Menon R; Heukamp LC; Thunnissen E; Ocak S Lung Cancer; 2016 Aug; 98():118-121. PubMed ID: 27393517 [TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of ALK testing and first-line crizotinib therapy for non-small-cell lung cancer in China. Lu S; Yu Y; Fu S; Ren H PLoS One; 2018; 13(10):e0205827. PubMed ID: 30352060 [TBL] [Abstract][Full Text] [Related]
19. Commentary: management of the patient. Johnston SR; Broadley K; Henson G; Fisher C; Henk M; Gore ME BMJ; 1998 Mar; 316(7134):851. PubMed ID: 9565458 [No Abstract] [Full Text] [Related]
20. Thyroid gland metastasis mimicking thyroid carcinoma in a lung cancer patient and dramatic response to crizotinib: A case report. Erul E; Güven DC; Şahin TK; Güllü İ Tuberk Toraks; 2021 Mar; 69(1):98-101. PubMed ID: 33853311 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]